XML 16 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Comprehensive Loss - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Statement of Comprehensive Income [Abstract]        
Net (loss) income $ (4,077,192) $ 38,465,008 $ (9,061,633) $ 28,671,684
Available for sale securities - net unrealized income (loss) 27,633 (57,860) (3,113) (57,860)
Total other comprehensive income (loss) 27,633 (57,860) (3,113) (57,860)
Comprehensive (loss) income (4,049,559) 38,407,148 (9,064,746) 28,613,824
Comprehensive loss attributable to noncontrolling interests (821) (254,001) (2,683) (687,498)
Comprehensive (loss) income attributable to Caladrius Biosciences, Inc. common stockholders $ (4,048,738) $ 38,661,149 $ (9,062,063) $ 29,301,322